You are about to leave a GSK website. By clicking this link you will be taken to a website that is independent from GSK. The site you are linking to is not controlled or endorsed by GSK and GSK is not responsible for its content.
×
You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.
Timeout
For US HCPs
For US Healthcare Professionals
Menu
Search
Follow Us
For appropriate patients faced with relapsed/ refractory multiple myeloma
Target BCMA for RRMM
BLENREP is the first and only BCMA-targeted ADC monotherapy. So you can offer your RRMM patients a different option.1
Connect with your local representative to learn more.
Get help connecting with eye care professionals near your practice.
Watch informative videos about MOA, patient access, and more.